-+ 0.00%
-+ 0.00%
-+ 0.00%

LISATA THERAPEUTICS, - TO USE NET PROCEEDS TO ADVANCE MAR001/005 AND MAR002 WITH TOPLINE PHASE 2 DATA EXPECTED Q4 2027

Reuters·09/17/2026 13:26:54

Please log in to view news